India's Accutest Research Labs expands into Latin America

Accutest Research Labs CEO Satish Sawant

Accutest Research Laboratories moved to expand in Latin America, announcing on Monday that it is establishing offices and operations in Brazil.

The Mumbai-based CRO, which performs bioavailability and bioequivalence studies for all key regulated markets, hopes to participate in and shape the potential of the Latin American CRO market, the Accutest said in a statement. It also hopes to contribute to the growth of the pharmaceutical sector in Brazil. But the company has designs on more than just Latin America.

"Opening offices in emerging countries to support drug development is a key element of our expansion strategy," said founder and CEO Satish Sawant. "We have identified seven emerging countries to develop operational capabilities, and by opening offices in Brazil, Malaysia and Taiwan we have completed our current expansion phase."

Brazil is a strategic choice for the CRO. According to the statement, of the more than 80 regulatory accreditations or approvals it has won from various regulatory agencies, 12 of them are from ANVISA in Brazil.

And that's not all it's got going for it in Brazil. Market surveys show that it is one of the fastest growing pharmaceutical markets in the world, with a large population, an investment friendly environment, an effective patent protection regime and a relatively low incidence of counterfeit drugs.

- read the release

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.